Kelyniam Global (KLYG) Sees 84% Revenue Surge with 'Fusion Implant', Focus on Profit Turnaround
Kelyniam Global announced significant Q1 2026 financial improvements, including an 84% revenue increase and a shift to operating profit, driven by its Fusion™ BCP-PEEK implant technology.
Get the next 8/10 catalyst
Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.1%.